-
emsCharts Announces Partnership with HealthCall
Post on 2/20/17
-
How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners
Post on 2/17/17
-
Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks
Post on 2/17/17
-
Quest Diagnostics Named One of 2017 "World's Most Admired Companies" by Fortune Magazine
Post on 2/16/17
-
Helius Medical Technologies Closes C$12.5 Million Public Offering
Post on 2/16/17
-
Johnson & Johnson Is Not Cheap, And It Never Will Be
Post on 2/16/17
-
No Joke: Johnson & Johnson Could Grow Sales by 5% (or More) Annually Over the Next Decade
Post on 2/16/17
-
Windtree Therapeutics Completes $10.5 Million Private Offering
Post on 2/15/17
-
Interleukin Genetics and Pittsburgh Business Group on Health Forge Relationship
Post on 2/15/17
-
Integra LifeSciences To Acquire the Codman Neurosurgery Business from Johnson & Johnson For $1.045B
Post on 2/15/17
-
Johnson & Johnson: Strong And Steady Dividend Champ
Post on 2/15/17
-
Teva Management's Brilliant Hidden Message
Post on 2/15/17
-
Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal
Post on 2/15/17
-
Quotient Clinical Acquires QS Pharma
Post on 2/14/17
-
3 Top Biotech Stocks to Buy on Sale
Post on 2/14/17
-
Teva Pharmaceutical Industries (TEVA) Q4 2016 Results - Earnings Call Transcript
Post on 2/14/17
-
IBB: Merck Joins The Drug Pricing Coalition For Transparency
Post on 2/14/17
-
Teva Pharmaceutical Industries Ltd. Reports Q4 Improvement Thanks to Actavis Deal
Post on 2/14/17
-
Fast Company Honors Braeburn Pharmaceuticals as a Top Ten Most Innovative Company in Biotech
Post on 2/13/17
-
Teva Will Report Higher-Than-Expected Income
Post on 2/13/17
-
Will Seattle Genetics' Deal With Immunomedics Get Scuttled?
Post on 2/13/17
-
3 Reasons Johnson & Johnson's Actelion Deal Might Not Be Totally Crazy
Post on 2/13/17
-
Immunomedics Enters into Global Licensing Agreement with Seattle Genetics
Post on 2/12/17
-
Valeritas Amends Existing Credit Facility to Extend Payment Obligations
Post on 2/10/17
-
Better Buy: Amgen Inc. vs. Celgene
Post on 2/9/17
Philadelphia
